Unbalanced estrogen metabolism in thyroid cancer

Int J Cancer. 2013 Dec 1;133(11):2642-9. doi: 10.1002/ijc.28275. Epub 2013 Jun 14.

Abstract

Well-differentiated thyroid cancer most frequently occurs in premenopausal women. Greater exposure to estrogens may be a risk factor for thyroid cancer. To investigate the role of estrogens in thyroid cancer, a spot urine sample was obtained from 40 women with thyroid cancer and 40 age-matched controls. Thirty-eight estrogen metabolites, conjugates and DNA adducts were analyzed by using ultraperformance liquid chromatography/tandem mass spectrometry and the ratio of adducts to metabolites and conjugates was calculated for each sample. The ratio of depurinating estrogen-DNA adducts to estrogen metabolites and conjugates significantly differed between cases and controls (p < 0.0001), demonstrating high specificity and sensitivity. These findings indicate that estrogen metabolism is unbalanced in thyroid cancer and suggest that formation of estrogen-DNA adducts might play a role in the initiation of thyroid cancer.

Keywords: estrogen-DNA adducts; thyroid cancer; unbalanced estrogen metabolism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers, Tumor / metabolism
  • Biomarkers, Tumor / urine
  • Chromatography, Liquid
  • DNA Adducts / urine*
  • Estrogens / metabolism*
  • Estrogens / urine*
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Risk Factors
  • Tandem Mass Spectrometry
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / urine*

Substances

  • Biomarkers, Tumor
  • DNA Adducts
  • Estrogens